Wird geladen...
Engineering Escherichia coli for Soluble Expression and Single Step Purification of Active Human Lysozyme
Genetically engineered variants of human lysozyme represent promising leads in the battle against drug-resistant bacterial pathogens, but early stage development and testing of novel lysozyme variants is constrained by the lack of a robust, scalable and facile expression system. While wild type huma...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Artigo |
Sprache: | Inglês |
Veröffentlicht: |
2012
|
Schlagworte: | |
Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3594478/ https://ncbi.nlm.nih.gov/pubmed/23220215 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jbiotec.2012.11.007 |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|